Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Carl Icahn. Photo: Heidi Gutman/CNBC/NBCU Photo Bank via Getty Images
The proposed merger between Cigna and Express Scripts would be a "travesty," activist investor Carl Icahn wrote in an open letter to shareholders this morning. Ichan said Amazon and the Trump administration, together, could challenge Express Scripts' "very existence" over the next few years.
Between the lines: Express Scripts is the country's biggest pharmacy benefit manager (PBM) — the middlemen between drug companies and insurance coverage. But the Trump administration is focusing on PBMs in its effort to bring down prescription drug prices, and Amazon is still looking to enter the pharmacy business.